A new study found that some cancer patients who took GLP-1 drugs saw some remission — especially if they had breast cancer.

CHICAGO — GLP-1 receptor agonists may help mitigate progression of at least some obesity-related cancers, according to retrospective study results presented at ASCO Annual…

Accumulating evidence of possible benefit warrants randomized trials, experts say